1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Ruminant Vaccines Market Outlook
4.1.
Market Size &
Forecast
4.1.1.
By Value
4.2.
Market Share &
Forecast
4.2.1. By Animal Type
(Cattle, Sheep & Goats)
4.2.2. By Vaccine Type
(Modified/ Attenuated Live, Inactivated
(Killed), Others)
4.2.3. By Vaccines
Indication (BVD Infection, Bovine
Respiratory Diseases (BRD), Leptospirosis,
Clostridial diseases, Diarrhea/ Scours, FMD, Others)
4.2.4. By Route of
Administration (Injectable, Intranasal)
4.2.5.
By Region
4.2.6.
By Company (2022)
4.3.
Market Map
4.3.1.
By Animal Type
4.3.2.
By Vaccine Type
4.3.3.
By Vaccines
Indication
4.3.4.
By Route of
Administration
4.3.5.
By Region
5. Asia Pacific Ruminant Vaccines Market Outlook
5.1.
Market Size &
Forecast
5.1.1.
By Value
5.2.
Market Share &
Forecast
5.2.1.
By Animal Type
5.2.2. By Vaccine Type
5.2.3.
By Vaccines
Indication
5.2.4. By Route of
Administration
5.2.5.
By Country
5.3.
Asia Pacific:
Country Analysis
5.3.1.
China Ruminant
Vaccines Market Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Animal Type
5.3.1.2.2.
By Vaccine Type
5.3.1.2.3.
By Vaccines Indication
5.3.1.2.4.
By Route of
Administration
5.3.2.
India Ruminant
Vaccines Market Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Animal Type
5.3.2.2.2.
By Vaccine Type
5.3.2.2.3.
By Vaccines Indication
5.3.2.2.4.
By Route of
Administration
5.3.3.
Australia Ruminant
Vaccines Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Animal Type
5.3.3.2.2.
By Vaccine Type
5.3.3.2.3.
By Vaccines Indication
5.3.3.2.4.
By Route of
Administration
5.3.4.
Japan Ruminant
Vaccines Market Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Animal Type
5.3.4.2.2.
By Vaccine Type
5.3.4.2.3.
By Vaccines Indication
5.3.4.2.4.
By Route of Administration
5.3.5.
South Korea Ruminant
Vaccines Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Animal Type
5.3.5.2.2.
By Vaccine Type
5.3.5.2.3.
By Vaccines Indication
5.3.5.2.4.
By Route of
Administration
6. Europe Ruminant Vaccines Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1. By Animal Type
6.2.2. By Vaccine Type
6.2.3. By Vaccines
Indication
6.2.4. By Route of
Administration
6.2.5. By Country
6.3.
Europe: Country
Analysis
6.3.1.
France Ruminant
Vaccines Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Animal Type
6.3.1.2.2.
By Vaccine Type
6.3.1.2.3.
By Vaccines Indication
6.3.1.2.4.
By Route of
Administration
6.3.2.
Germany Ruminant
Vaccines Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Animal Type
6.3.2.2.2.
By Vaccine Type
6.3.2.2.3.
By Vaccines
Indication
6.3.2.2.4.
By Route of
Administration
6.3.3.
Spain Ruminant
Vaccines Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Animal Type
6.3.3.2.2.
By Vaccine Type
6.3.3.2.3.
By Vaccines
Indication
6.3.3.2.4.
By Route of
Administration
6.3.4.
Italy Ruminant
Vaccines Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Animal Type
6.3.4.2.2.
By Vaccine Type
6.3.4.2.3.
By Vaccines
Indication
6.3.4.2.4.
By Route of
Administration
6.3.5.
United Kingdom
Ruminant Vaccines Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Animal Type
6.3.5.2.2.
By Vaccine Type
6.3.5.2.3.
By Vaccines Indication
6.3.5.2.4.
By Route of
Administration
7. North America Ruminant Vaccines Market Outlook
7.1.
Market Size &
Forecast
7.1.1.
By Value
7.2.
Market Share &
Forecast
7.2.1. By Animal Type
7.2.2. By Vaccine Type
7.2.3. By Vaccines
Indication
7.2.4. By Route of Administration
7.2.5.
By Country
7.3.
North America:
Country Analysis
7.3.1.
United States
Ruminant Vaccines Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Animal Type
7.3.1.2.2.
By Vaccine Type
7.3.1.2.3.
By Vaccines Indication
7.3.1.2.4.
By Route of
Administration
7.3.2.
Mexico Ruminant
Vaccines Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Animal Type
7.3.2.2.2.
By Vaccine Type
7.3.2.2.3.
By Vaccines Indication
7.3.2.2.4.
By Route of
Administration
7.3.3.
Canada Ruminant
Vaccines Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Animal Type
7.3.3.2.2.
By Vaccine Type
7.3.3.2.3.
By Vaccines
Indication
7.3.3.2.4.
By Route of
Administration
8. South America Ruminant Vaccines Market Outlook
8.1.
Market Size &
Forecast
8.1.1.
By Value
8.2.
Market Share &
Forecast
8.2.1. By Animal Type
8.2.2. By Vaccine Type
8.2.3. By Vaccines Indication
8.2.4. By Route of
Administration
8.2.5.
By Country
8.3.
South America:
Country Analysis
8.3.1.
Brazil Ruminant
Vaccines Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Animal Type
8.3.1.2.2.
By Vaccine Type
8.3.1.2.3.
By Vaccines Indication
8.3.1.2.4.
By Route of Administration
8.3.2.
Argentina Ruminant
Vaccines Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Animal Type
8.3.2.2.2.
By Vaccine Type
8.3.2.2.3.
By Vaccines
Indication
8.3.2.2.4.
By Route of
Administration
8.3.3.
Colombia Ruminant
Vaccines Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Animal Type
8.3.3.2.2.
By Vaccine Type
8.3.3.2.3.
By Vaccines Indication
8.3.3.2.4.
By Route of
Administration
9. Middle East and Africa Ruminant Vaccines Market Outlook
9.1.
Market Size &
Forecast
9.1.1.
By Value
9.2.
Market Share &
Forecast
9.2.1. By Animal Type
9.2.2. By Vaccine Type
9.2.3. By Vaccines
Indication
9.2.4. By Route of
Administration
9.2.5.
By Country
9.3.
MEA: Country
Analysis
9.3.1.
South Africa
Ruminant Vaccines Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Animal Type
9.3.1.2.2.
By Vaccine Type
9.3.1.2.3.
By Vaccines Indication
9.3.1.2.4.
By Route of
Administration
9.3.2.
Saudi Arabia
Ruminant Vaccines Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Animal Type
9.3.2.2.2.
By Vaccine Type
9.3.2.2.3.
By Vaccines Indication
9.3.2.2.4.
By Route of
Administration
9.3.3.
UAE Ruminant
Vaccines Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Animal Type
9.3.3.2.2.
By Vaccine Type
9.3.3.2.3.
By Vaccines
Indication
9.3.3.2.4.
By Route of
Administration
10.
Market Dynamics
10.1.
Drivers
10.2.
Challenges
11.
Market Trends &
Developments
11.1.
Recent Developments
11.2.
Product Launches
11.3.
Mergers &
Acquisitions
12.
Global Ruminant
Vaccines Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Product
14.
Competitive
Landscape
14.1. Boehringer
Ingelheim International GmbH
14.1.1.
Business Overview
14.1.2.
Company Snapshot
14.1.3.
Product &
Services
14.1.4.
Current Capacity
Analysis
14.1.5.
Financials (In case
of listed)
14.1.6.
Recent Developments
14.1.7.
SWOT Analysis
14.2. Zoetis Services LLC
14.3. Vaxxinova International BV
14.4. Merck & Co., Inc.
14.5. Bimeda Animal Health Ltd.
14.6. Indian Immunologicals Ltd.
14.7. Elanco Animal Health
Incorporated
14.8. Virbac
14.9. Ceva Santé Animale
14.10.CZ Vaccines S.A.U.
(Zendal Group)
15.
Strategic Recommendations
16.
About Us & Disclaimer